Bangkok Dusit Medical Services Public Company Limited
Bangkok Dusit Medical Services Public Company Limited Fundamental Analysis
Bangkok Dusit Medical Services Public Company Limited (BDUUF) shows moderate financial fundamentals with a PE ratio of 21.26, profit margin of 13.94%, and ROE of 14.90%. The company generates $111.6B in annual revenue with moderate year-over-year growth of 3.37%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 54.1/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze BDUUF's fundamental strength across five key dimensions:
Efficiency Score
WeakBDUUF struggles to generate sufficient returns from assets.
Valuation Score
ExcellentBDUUF trades at attractive valuation levels.
Growth Score
WeakBDUUF faces weak or negative growth trends.
Financial Health Score
ExcellentBDUUF maintains a strong and stable balance sheet.
Profitability Score
WeakBDUUF struggles to sustain strong margins.
Key Financial Metrics
Is BDUUF Expensive or Cheap?
P/E Ratio
BDUUF trades at 21.26 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, BDUUF's PEG of -0.13 indicates potential undervaluation.
Price to Book
The market values Bangkok Dusit Medical Services Public Company Limited at 3.00 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 12.47 times EBITDA. This signals the market has high growth expectations.
How Well Does BDUUF Make Money?
Net Profit Margin
For every $100 in sales, Bangkok Dusit Medical Services Public Company Limited keeps $13.94 as profit after all expenses.
Operating Margin
Core operations generate 16.91 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $14.90 in profit for every $100 of shareholder equity.
ROA
Bangkok Dusit Medical Services Public Company Limited generates $9.67 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Bangkok Dusit Medical Services Public Company Limited produces operating cash flow of $16.09B, showing steady but balanced cash generation.
Free Cash Flow
Bangkok Dusit Medical Services Public Company Limited produces free cash flow of $9.50B, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.60 in free cash annually.
FCF Yield
BDUUF converts 2.87% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
21.26
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.13
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.00
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.96
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.13
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.16
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.15
vs 25 benchmark
ROA
Return on assets percentage
0.10
vs 25 benchmark
ROCE
Return on capital employed
0.14
vs 25 benchmark
How BDUUF Stacks Against Its Sector Peers
| Metric | BDUUF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 21.26 | 29.38 | Better (Cheaper) |
| ROE | 14.90% | 739.00% | Weak |
| Net Margin | 13.94% | -53619.00% (disorted) | Strong |
| Debt/Equity | 0.13 | 0.39 | Strong (Low Leverage) |
| Current Ratio | 1.16 | 4.03 | Neutral |
| ROA | 9.67% | -20116.00% (disorted) | Weak |
BDUUF outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Bangkok Dusit Medical Services Public Company Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
63.80%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
119.68%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
100.74%
Industry Style: Defensive, Growth, Innovation
High Growth